Responses
Immune cell therapies and immune cell engineering
Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19+ malignancy
Compose a Response to This Article
Other responses
No responses have been published for this article.